Gaining Deeper Insights into the Surface Binding of Bedaquiline Analogues with ATP Synthase Subunit C of Mycobacterium tuberculosis Using Molecular Docking, Molecular Dynamics Simulation and 3D-QSAR Techniques

New J. Chem., 2020, Accepted Manuscript DOI: 10.1039/D0NJ02062A, PaperManisha Lobo, Rajdeep Ray, Gautham G. Shenoy Bedaquiline is a diarylquinoline antimycobacterial drug prescribed for the treatment of Multidrug-Resistant Tuberculosis (MDR-TB). It targets the energy metabolism of the bacteria by inhibiting the proton pump of mycobacterial ATP... The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - New J. Chem. latest articles - September 22, 2020 Category: Chemistry Authors: Manisha Lobo Source Type: research